Literature DB >> 16595673

Copper-mediated amyloid-beta toxicity is associated with an intermolecular histidine bridge.

David P Smith1, Danielle G Smith, Cyril C Curtain, John F Boas, John R Pilbrow, Giuseppe D Ciccotosto, Tong-Lay Lau, Deborah J Tew, Keyla Perez, John D Wade, Ashley I Bush, Simon C Drew, Frances Separovic, Colin L Masters, Roberto Cappai, Kevin J Barnham.   

Abstract

Amyloid-beta peptide (Abeta) is pivotal to the pathogenesis of Alzheimer disease. Here we report the formation of a toxic Abeta-Cu2+ complex formed via a histidine-bridged dimer, as observed at Cu2+/peptide ratios of >0.6:1 by EPR spectroscopy. The toxicity of the Abeta-Cu2+ complex to cultured primary cortical neurons was attenuated when either the pi -or tau-nitrogen of the imidazole side chains of His were methylated, thereby inhibiting formation of the His bridge. Toxicity did not correlate with the ability to form amyloid or perturb the acyl-chain region of a lipid membrane as measured by diphenyl-1,3,5-hexatriene anisotropy, but did correlate with lipid peroxidation and dityrosine formation. 31P magic angle spinning solid-state NMR showed that Abeta and Abeta-Cu2+ complexes interacted at the surface of a lipid membrane. These findings indicate that the generation of the Abeta toxic species is modulated by the Cu2+ concentration and the ability to form an intermolecular His bridge.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16595673     DOI: 10.1074/jbc.M600417200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

Review 1.  The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes.

Authors:  Iryna Benilova; Eric Karran; Bart De Strooper
Journal:  Nat Neurosci       Date:  2012-01-29       Impact factor: 24.884

Review 2.  Neurotoxicity in Alzheimer's disease: is covalently crosslinked A beta responsible?

Authors:  Ryan Naylor; Andrew F Hill; Kevin J Barnham
Journal:  Eur Biophys J       Date:  2007-12-07       Impact factor: 1.733

Review 3.  How is protein aggregation in amyloidogenic diseases modulated by biological membranes?

Authors:  Christopher Aisenbrey; Tomasz Borowik; Roberth Byström; Marcus Bokvist; Fredrick Lindström; Hanna Misiak; Marc-Antoine Sani; Gerhard Gröbner
Journal:  Eur Biophys J       Date:  2007-11-21       Impact factor: 1.733

4.  Nanoprobing of the effect of Cu(2+) cations on misfolding, interaction and aggregation of amyloid β peptide.

Authors:  Zhengjian Lv; Margaret M Condron; David B Teplow; Yuri L Lyubchenko
Journal:  J Neuroimmune Pharmacol       Date:  2012-11-11       Impact factor: 4.147

Review 5.  Twenty years of metallo-neurobiology: where to now?

Authors:  Ashley I Bush; Cyril C Curtain
Journal:  Eur Biophys J       Date:  2007-11-10       Impact factor: 1.733

Review 6.  Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease.

Authors:  Ghiam Yamin; Kenjiro Ono; Mohammed Inayathullah; David B Teplow
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

7.  Capturing a reactive state of amyloid aggregates: NMR-based characterization of copper-bound Alzheimer disease amyloid β-fibrils in a redox cycle.

Authors:  Sudhakar Parthasarathy; Brian Yoo; Dan McElheny; William Tay; Yoshitaka Ishii
Journal:  J Biol Chem       Date:  2014-02-12       Impact factor: 5.157

8.  A prochelator activated by hydrogen peroxide prevents metal-induced amyloid Beta aggregation.

Authors:  Marina G Dickens; Katherine J Franz
Journal:  Chembiochem       Date:  2010-01-04       Impact factor: 3.164

9.  Modulation of amyloid-β aggregation by histidine-coordinating Cobalt(III) Schiff base complexes.

Authors:  Marie C Heffern; Pauline T Velasco; Lauren M Matosziuk; Joseph L Coomes; Constantine Karras; Mark A Ratner; William L Klein; Amanda L Eckermann; Thomas J Meade
Journal:  Chembiochem       Date:  2014-06-24       Impact factor: 3.164

10.  HH domain of Alzheimer's disease Abeta provides structural basis for neuronal binding in PC12 and mouse cortical/hippocampal neurons.

Authors:  Joseph F Poduslo; Emily J Gilles; Muthu Ramakrishnan; Kyle G Howell; Thomas M Wengenack; Geoffry L Curran; Karunya K Kandimalla
Journal:  PLoS One       Date:  2010-01-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.